Explore life science & biotech companies in Oxford, home to one of the world's leading biotechnology and life science clusters.
Generative AI and quantum chemistry platform for de novo enzyme design
Xyme is a biotechnology company developing a generative AI and quantum chemistry platform for designing novel enzymes from first principles. Its approach combines computational…
Bacteriophage-integrated antibacterial textiles for surgical implant infection prevention
Oxford Silk Phage Technologies is a biotechnology company developing antibacterial biomaterials that integrate bacteriophages into silk-based medical textiles, for use in surgical…
Oligonucleotide therapeutics designed to upregulate protein expression
Orfonyx Bio is a biotechnology company developing genetic medicines that increase, rather than silence, the expression of therapeutic target proteins. Its platform generates…
Exosome-delivered gene editing therapies for neurodegenerative diseases
Evox Therapeutics is a biotechnology company developing exosome-based gene editing therapies for rare, genetically driven neurodegenerative diseases. Its proprietary platform uses…
Oxford University spinout producing cultivated beef and pork
Ivy Farm Technologies is a company developing cultivated meat using a non-GMO cell culture process originally developed at the University of Oxford. Its Oxford pilot plant…
AI-powered point-of-care genomic sequencing for hospitals and clinics
SiGenex Oxford is the UK research and development arm of SiGenex, developing an AI-powered, decentralised platform for point-of-care genomic and multi-omic diagnostics. The…
Automated single-cell isolation and cloning instruments for cell biology
Iota Sciences is a developer of automated single-cell handling instruments and cell-line engineering services. The company's platform automates single-cell isolation and cloning…
Next-generation lipid nanoparticle platform for RNA vaccines and medicines
NeoVac is a biotechnology company developing a next-generation lipid nanoparticle platform to improve the delivery of RNA vaccines and therapeutics. Its library of fully…
GPR35 inhibitors for gastrointestinal cancer and inflammatory bowel disease
ThirtyFiveBio is a drug discovery company developing first-in-class small molecule inhibitors of GPR35, a genetically validated G protein-coupled receptor implicated in…
Oxford University's biomedical start-up incubator and lab space
The BioEscalator is the University of Oxford's biomedical incubator, providing flexible laboratory and office space to early-stage life science companies on the Old Road Campus.…
High-throughput iPSC reprogramming and stem cell drug discovery services
Oxford StemTech is a contract research company providing induced pluripotent stem cell (iPSC) reprogramming and drug discovery services using its proprietary platform. The…
AI-driven T-cell receptor discovery platform for solid tumour immunotherapies
Exogene is an Oxford biotech developing TCR-based immunotherapies for solid tumours. Its platform integrates generative AI, biophysical simulation, and high-throughput TCR-antigen…